Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

IGF-1 may affect hair growth and loss, but more research is needed to confirm effective and safe treatments.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

The hairless gene is crucial for hair health, and its mutations cause hair loss.

Sex hormone supplements help improve breathing and nerve recovery after spinal injury in rats.

TDM10842, a thyroid hormone receptor activator, was found to effectively promote hair growth in mice.

Individualized treatment improves symptoms and quality of life for women with PCOS.

CRH can cause hair loss by promoting cell death in hair growth cells.

Treating hyperprolactinemia can help manage PCOS symptoms.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Different types of hair loss in dogs and cats have various causes and treatments, with outcomes ranging from good to uncertain.

Alopecia in animals can be hereditary, congenital, or acquired, with treatments and outcomes varying widely.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Advancements in hair biology include new treatments and tools for hair growth and alopecia.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

GnRH analogue can help diagnose ovarian causes of high testosterone in postmenopausal women when scans don't show the cause.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

More research is needed to understand how testosterone is maintained in adult males.

Follicle Stimulating Hormone is important for fertility.

Using neurohormones to control keratin can lead to new skin disease treatments.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

Regenerative medicine uses combined treatments to boost natural healing and improve health, especially for aging.

Testosterone treatment may change estrogen receptor methylation in AFAB individuals.

Vitamin D is important for bones, hair, blood pressure, and breast development.